Raymond James analyst Felix Boeschen downgrades C.H. Robinson Worldwide (NASDAQ:CHRW) from Market Perform to Underperform.
BridgeBio Pharma Shares Are Shooting Higher Today – Here’s Why
BridgeBio Pharma Inc (NASDAQ: BBIO) released results from ATTRibute-CM Phase 3 study of acoramidis in transthyretin